Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 210.98M P/E - EPS this Y -7.10% Ern Qtrly Grth -
Income -37.98M Forward P/E -5.56 EPS next Y 12.40% 50D Avg Chg -17.00%
Sales 52.69M PEG - EPS past 5Y - 200D Avg Chg -28.00%
Dividend N/A Price/Book 1.16 EPS next 5Y - 52W High Chg -75.00%
Recommedations 1.20 Quick Ratio 4.07 Shares Outstanding 34.66M 52W Low Chg 15.00%
Insider Own 7.64% ROA -13.49% Shares Float 26.29M Beta 0.98
Inst Own 72.76% ROE -22.96% Shares Shorted/Prior 1.32M/1.37M Price 6.56
Gross Margin 52.32% Profit Margin -72.10% Avg. Volume 231,262 Target Price 15.00
Oper. Margin -96.53% Earnings Date Nov 5 Volume 107,307 Change -0.91%
About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

908 Devices Inc. News
11/15/24 Analysts Have Lowered Expectations For 908 Devices Inc. (NASDAQ:MASS) After Its Latest Results
11/14/24 908 Devices Third Quarter 2024 Earnings: Misses Expectations
11/13/24 908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges
11/12/24 908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates
11/12/24 908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
11/06/24 US Penny Stocks: 908 Devices Leads This Trio
11/04/24 908 Devices to Participate in Upcoming Investor Conferences
10/22/24 908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
10/09/24 908 Devices Inc (MASS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
09/09/24 908 Devices Inc. (NASDAQ:MASS) is favoured by institutional owners who hold 57% of the company
09/06/24 908 Devices to Participate in Craig-Hallum Bioprocessing Conference
08/06/24 908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
08/06/24 908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
07/31/24 ClearPoint Neuro, Inc. (CLPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
07/30/24 Earnings Preview: 908 Devices Inc. (MASS) Q2 Earnings Expected to Decline
07/30/24 908 Devices Insider Ups Holding During Year
07/30/24 908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
07/23/24 908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
06/25/24 908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
06/18/24 908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
MASS Chatroom

User Image Helloa11 Posted - 1 day ago

$MASS wow - this is green today ! Touching wood 😝

User Image Helloa11 Posted - 2 days ago

$MASS Come on 🏃‍♂️!

User Image zeph1985 Posted - 3 days ago

$MASS

User Image hermitkatt Posted - 5 days ago

$MASS start a position here

User Image lucianw Posted - 6 days ago

$MASS my only green stock (so far) today. glad I more than doubled my position post earning.

User Image PLATINUM_TRADES Posted - 6 days ago

$MASS $2.70's not far fetched!!

User Image zeph1985 Posted - 6 days ago

$MASS it must go up

User Image RETAlerts Posted - 1 week ago

$MASS at 2.38 has shown some initial momentum, and is up since landing on our scanner, let's see if any overhead resistance levels get broken with conviction. (15 minute delay)

User Image zeph1985 Posted - 1 week ago

$MASS it starts

User Image Chiroptera_Capital Posted - 1 week ago

$MASS

User Image RocketThief Posted - 1 week ago

$MASS EV now ~$22M, less than half of guided ‘24 revenue. Adding more

User Image Helloa11 Posted - 1 week ago

$MASS Added at 2.79.

User Image LewisDaKat Posted - 1 week ago

News $MASS 908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook https://marketwirenews.com/news-releases/908-devices-reports-third-quarter-2024-financial-res-5389022874632769.html $MASS

User Image Chiroptera_Capital Posted - 1 week ago

$MASS maybe I should quit buying so this thing can finally go up

User Image Helloa11 Posted - 1 week ago

$MASS ADDED !

User Image RocketThief Posted - 1 week ago

$MASS not a great quarter but will try a swing here on valuation

User Image Chiroptera_Capital Posted - 1 week ago

$MASS selloff seems overdone

User Image ChessGM Posted - 1 week ago

$MASS Heads up alert! Upcoming earnings on Tuesday, 11/12/2024 for $MASS Neutral (5.5) In evaluating 908 Devices Inc. (MASS), it is essential to consider both the company’s financial performance and its positioning within the market. The latest earnings call highlighted a commendable 16% revenue growth, indicating robust demand for its handheld devices despite challenging macroeconomic conditions. However, the company also reported an increased net loss, which raises concerns about profitability and operational efficiency. As of now, the company's P/E ratio is not readily available due to its current net losses, yet analysts project a forward P/E ratio that might reflect improving earnings as the company stabilizes its expenses. The EPS growth trajectory is under scrutiny, particularly given the current environment and the competitive landscape within the chemical analysis sector. 908 Devices is anticipated to continue focusing on innovation and customer engagement to bolster revenue further. Comparing 908 Devices to industry peers, the overall market sentiment remains cautiously optimistic. While some competitors have reported stronger margins, 908 Devices’ growth rate positions it favorably, especially if it can convert revenue growth into sustainable profitability. Furthermore, upcoming earnings on November 12, 2024, are pivotal, as expectations are set for a continued revenue increase. Analysts are forecasting a consensus estimate of approximately 0.15 EPS, signaling a potential turnaround from previous quarters. Historical performance has shown volatility, but any positive surprises in the upcoming report could significantly enhance the stock's outlook. In summary, while 908 Devices has shown promising revenue growth, the increased loss coupled with market uncertainties necessitates a balanced perspective. The impending earnings report will be crucial in shaping investor confidence and setting future performance expectations. - Funds were net buyers of $MASS during the previous reporting quarter. - Top 2 funds with large holdings in $MASS: * ARK Investment Management LLC $20MM. New position. CGMFundRank: 61%, Fund Website: www.ark-invest.com * Granahan Investment Management Inc $5MM. New position. CGMFundRank: 69%, Fund Website: www.granahan.com - Last 10 days performance: 15% - Last 30 days performance: 12% - Last 90 days performance: -10% Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.

User Image Helloa11 Posted - 2 weeks ago

$MASS What the heck is happening here ? No any news but falling down like a rock.

User Image Ava_Parker Posted - 2 weeks ago

$MASS $CBUS MYNZ +10.91% PM LFG, unusually high volume activity last week, apx 30% more than average. 👇😘🚀 This stock may see the last time this price per share PT $5+ 🚀 HUGE PRs drop incoming before the Nov 13 meeting, so compliance is coming—no RS needed. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead.

User Image ai36r Posted - 10/29/24

$MASS ✅ 📈

User Image Helloa11 Posted - 10/25/24

$MASS Added at $3.27.

User Image Chiroptera_Capital Posted - 10/24/24

$MASS looks like cathie quit selling in September. Decent earnings report would reverse the downtrend she put us on. Seems cheap here to me.

User Image lucianw Posted - 1 month ago

$MASS this board is so quiet. anyone has any insights with this company?

User Image Chiroptera_Capital Posted - 1 month ago

$MASS Let’s see if this is the bottom. We’re at 0.5 EV/revenue. While there’s still some cash burn ahead there appears to be a realistic pathway to profitability, and hopefully with interest rates going down and global liquidity increasing, there’ll be a capex cycle for their products

User Image Righon23420 Posted - 09/23/24

$MASS This is a bargain in the 3’s. This looks like a great acquisition target for $TMO

User Image RocketThief Posted - 2 months ago

$MASS seems attractive at these levels but with Cathy there is never a floor

User Image Chiroptera_Capital Posted - 2 months ago

$MASS fuck cathie wood. The bid has been getting sold for a month straight

User Image Helloa11 Posted - 2 months ago

$MASS Added a little . What the heck ?

User Image GoodNewsBull Posted - 2 months ago

Wow, looks like someone's mad that Im posting his trades while he's posting MEME's about Dems,... I understand but still wont change the fact he bought $djt over $MASS Het @Max22, Did Harris have you Buying & pumping $mara over $30 this year? Was that her "Communist" agenda? 🤣 My man if you cant take the heat stay out of the bad trades $rum $meta

Analyst Ratings
Stephens & Co. Overweight May 13, 24
Stephens & Co. Overweight Sep 25, 23
Stephens & Co. Overweight Feb 7, 23
SVB Leerink Outperform Jan 6, 23
SVB Leerink Outperform Nov 15, 22
SVB Leerink Outperform Mar 8, 22
SVB Leerink Outperform May 14, 21
Stifel Buy Jan 12, 21
Cowen & Co. Outperform Jan 12, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 7.03 15,409 108,325 80,000 02/02/24
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Dec 28 Sell 12.08 6,000 72,480 80,000 01/02/24
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Dec 19 Sell 9.08 5,580 50,666 86,000 12/21/23
Brown Christopher D. Chief Product Office.. Chief Product Officer Dec 19 Sell 9.1 20,000 182,000 877,905 12/21/23
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Mar 22 Option 1.58 5,000 7,900 96,580 03/23/23
Turner Michael S. VP, General Counsel VP, General Counsel Feb 01 Sell 9.6 4,427 42,499 02/03/23
Knopp Kevin J. President and CEO President and CEO Feb 01 Sell 9.94 44,049 437,847 447,848 02/03/23
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 9.6 5,102 48,979 91,580 02/03/23
Fitzpatrick Maura VP, Product Manageme.. VP, Product Management & Mktg Feb 01 Sell 9.2 1,593 14,656 2,834 02/03/23
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Feb 01 Sell 9.6 11,564 111,014 902,375 02/03/23
Turner Michael S. VP, General Counsel VP, General Counsel Aug 17 Option 7.91 5,000 39,550 5,000 08/18/22
Turner Michael S. VP, General Counsel VP, General Counsel Aug 17 Sell 18.15 5,000 90,750 08/18/22
Knopp Kevin J. President and CEO President and CEO Aug 15 Sell 19.48 30,000 584,400 560,642 08/17/22
Knopp Kevin J. President and CEO President and CEO Aug 05 Sell 25.25 26,196 661,449 590,642 08/09/22
Knopp Kevin J. President and CEO President and CEO Jul 28 Sell 22.23 38,347 852,454 616,838 08/01/22
Knopp Kevin J. President and CEO President and CEO Jul 21 Sell 22.04 200 4,408 655,185 07/25/22
Knopp Kevin J. President and CEO President and CEO Jul 15 Sell 17.27 30,000 518,100 655,385 07/19/22
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Jul 06 Sell 21.41 10,000 214,100 928,912 07/08/22
Knopp Kevin J. President and CEO President and CEO Jul 06 Sell 22.07 1,453 32,068 685,385 07/08/22
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Jun 24 Option 0.96 18,188 17,460 96,639 06/27/22
Griffith Joseph H. IV Chief Financial Offi.. Chief Financial Officer Jun 24 Sell 19.11 18,188 347,573 91,580 06/27/22
Turner Michael S. VP, General Counsel VP, General Counsel Jun 23 Option 7.91 10,000 79,100 15,000 06/27/22
Turner Michael S. VP, General Counsel VP, General Counsel Jun 23 Sell 17.9 10,000 179,000 5,000 06/27/22
Kenneweg John Vice President, Gove.. Vice President, Government Apr 12 Option 0.35 9,880 3,458 9,880 04/14/22
Kenneweg John Vice President, Gove.. Vice President, Government Apr 12 Sell 20.07 9,880 198,292 04/14/22
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Apr 12 Sell 20.06 9,829 197,170 959,083 04/14/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Apr 11 Option 1.75 30,000 52,500 90,000 04/13/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Apr 11 Sell 19.96 15,000 299,400 75,000 04/13/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 18 Option 0.35 19,881 6,958 19,881 03/21/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 18 Sell 20.06 19,881 398,813 03/21/22
Brown Christopher D. Chief Technology Off.. Chief Technology Officer Mar 11 Sell 20.00 100 2,000 988,812 03/15/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 11 Sell 20 119 2,380 03/15/22
Kenneweg John Vice President, Gove.. Vice President, Government Mar 11 Option 0.35 119 42 119 03/15/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Mar 14 Option 2.5 15,000 37,500 75,000 03/15/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Mar 14 Sell 17.71 15,000 265,650 60,000 03/15/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Feb 14 Option 1.75 15,000 26,250 54,292 02/16/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Feb 14 Sell 15.17 15,000 227,550 45,000 02/16/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Jan 12 Option 1.75 15,000 26,250 60,000 01/14/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Jan 12 Sell 19.81 15,000 297,150 45,000 01/14/22
Kenneweg John Vice President, Gove.. Vice President, Government Jan 10 Option 0.35 10,000 3,500 9,300 01/12/22
Kenneweg John Vice President, Gove.. Vice President, Government Jan 10 Sell 20.1 10,000 201,000 01/12/22
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Aug 25 Sell 34.42 36,997 1,273,437 35,000 08/25/21
Basarsky Trent A. VP, Corporate Develo.. VP, Corporate Development Aug 25 Option 1.75 36,997 64,745 36,600 08/25/21